Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression

NCT00226343 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT00226343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression
Lead sponsor
Cambridge Health Alliance
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2003
Completion date
August 31, 2006
Enrollment
25
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder